Novartis AG ADR (NVS) earnings
In the quarter ended June 2025, Novartis AG ADR had revenue of —, and diluted EPS of 2.06.
On July 21, 2026 it reported EPS of 2.41 against an estimate of 2.20 (beat).
The next report is expected on Tuesday, October 27, 2026 before the market opens, with EPS expected around 2.25.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Tue Oct 27, 2026 | Before open | 2.25 | — |
| Last | Tue Jul 21, 2026 | Before open | 2.20 | 2.41 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 9 quarters from Novartis AG ADR's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2025 | — | — | 2.06 | +60.9% | — | 2025-07-17 |
| Jun 30, 2024 | — | — | 1.59 | +96.3% | — | 2024-07-18 |
| Jun 30, 2023 | — | — | 1.11 | -61.9% | — | 2023-07-18 |
| Jun 30, 2022 | — | — | 0.77 | -76.7% | — | 2022-07-19 |
| Jun 30, 2021 | — | — | 1.28 | +54.2% | — | 2021-07-21 |
| Jun 30, 2020 | — | — | 0.81 | — | — | 2020-07-21 |
| Jun 30, 2019 | — | — | 2.91 | — | — | 2019-07-18 |
| Jun 30, 2018 | — | — | 3.31 | — | — | 2018-07-18 |
| Jun 30, 2017 | — | — | 0.83 | — | — | 2018-07-18 |
Questions
When does Novartis AG ADR report earnings?
Novartis AG ADR's next earnings report is expected on October 27, 2026 before the market opens.
How did Novartis AG ADR do last quarter?
In the quarter ended June 2025, Novartis AG ADR had revenue of —, and diluted EPS of 2.06.
From Novartis AG ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.